Adrenal insufficiency development during chemotherapy plus anti-programmed death receptor-1 monoclonal antibody (tislelizumab) therapy in patients with advanced gastric cancer: two case reports

Immune checkpoint inhibitor (ICI)-associated adrenal insufficiency is rare but may become a serious adverse event in patients treated with ICIs. The present case report documents two cases of adrenal insufficiency developed during chemotherapy plus tislelizumab (百泽安, Baize’an; BeiGene Ltd.) therapy...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Hoofdauteur: Jin Ho Baek
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Yeungnam University College of Medicine, Yeungnam University Institute Medical Science 2022-01-01
Reeks:Journal of Yeungnam Medical Science
Onderwerpen:
adverse events
immune checkpoint inhibitors
stomach neoplasms
tislelizumab
Online toegang:http://www.e-jyms.org/upload/pdf/yujm-2021-00934.pdf
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items